JDRF’s South Jersey Chapter announced on July 19th, 2017 that Mayor David Mayer of Gloucester Township will serve as the Corporate Chair for JDRF’s 2017 One Walk®, to be held at Camden County College, Blackwood Campus, on Sunday, October 22, 2017. The event, organized by JDRF South Jersey Chapter, is expected to attract more than 6,000 supporters representing local businesses, families, schools, and other organizations. The event is one of more than 200 community JDRF One Walks nationwide that bring together hundreds of thousands of people each year who share JDRF’s vision to create a world without T1D by raising money to help fund critically needed type 1 diabetes research.
Mayer has served as Mayor of Gloucester Township since 2009. Since taking office, Mayer has worked on improving the Township’s finances and stabilizing taxes. He promoted new community policing initiatives and significantly enhanced economic development opportunities. In 2016, JDRF One Walk partnered with Gloucester Township to host the walk at Camden County College.
“Finding a cure for type one diabetes is a cause Mayor Mayer wholeheartedly believes in, and he knows that involving more people means we’ll get to that cure more quickly.” said Tom Deeney, the chapter’s Board President. “From the minute he agreed to serve as Chair, he jumped in with both feet, rallying tremendous support for JDRF throughout the community.”
“I know that JDRF research has made a huge difference for children and adults who live with this disease day in and day out,” said Mayer. “This is a very important cause that I am happy to support—and happy to enlist others to join me.”
The world’s largest T1D event, JDRF One Walk brings together more than 900,000 people at 205 Walks around the U.S. to raise money for T1D research. One Walk raises more than $63 million annually through the combined efforts of more than 20,500 family and school teams and 5,300 corporate teams.
Along with the One Walk in Gloucester Township, the South Jersey Chapter of JDRF hosts One Walk in the spring in Wildwood at Morey’s Piers. The chapter’s events deliver over $750K annually for T1D research.
The JDRF One Walk in Gloucester Township will take place on Sunday, October 22, 2017, at Camden County College, Blackwood Campus. Check-in begins at 8am, with the Walk kicking off at 10 am.
Individuals, businesses, and teams can participate in the South Jersey Chapter’s One Walk by registering online at walk.jdrf.org/southjersey
About Type 1 Diabetes
Type 1 diabetes is a chronic, life-threatening autoimmune disease that strikes children and adults at any age. In type 1 diabetes, the body’s immune system destroys the cells that release insulin, eventually eliminating insulin production from the body. Type 1 diabetes requires rigorous 24/7 monitoring of blood glucose levels to avoid devastating complications. T1D onset is sudden and unpreventable and it is unrelated to diet or lifestyle.
JDRF One Walk is the largest and most powerful peer-to-peer fundraising program in the world for T1D, raising more than $68 million annually. Since 1992, the event has raised more than $1 billion dollars for T1D research. This funding has enabled the search to find ways of preventing, delaying or halting the progression of T1D, and ultimately curing it; and has led to, life-changing drugs, treatments and devices many of which have already moved into clinical trials and real-world testing.
“JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested nearly $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers in 96 locations throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D.”